The new tool provides immediate access to the MarketScan Research Databases, which contain records for 300 million cumulative lives and 95 million active patients. By removing the requirement for deep programming expertise or manual code entry, the platform enables users to rapidly assess cohort feasibility and evaluate care journeys, utilization, and real-world costs.

John E. Linnehan, vice president and head of real-world data at Truven, stated that the transition from initial inquiry to evidence generation currently creates a significant bottleneck in the research community. MarketScan Snapshot addresses this by offering a summary statistics dashboard that helps analysts determine if a full-scale study is warranted without diverting extensive technical resources. The system draws on the company’s longitudinal data assets, which maintain 99% claims completeness and capture patient tracking for an average of 4.25 years. Qualified organizations can now request complimentary access to the platform to evaluate how the data aligns with their specific research objectives.